
At the dbAccess Global Consumer Conference, Mondelez (MDLZ) outlined its strategy for navigating economic challenges, including cocoa price inflation, by leveraging its global presence, particularly strong performance in Europe and emerging markets. The company is implementing pricing and revenue growth management impacting about 50% of chocolate revenue, expanding into adjacent categories like cakes and pastries, and prioritizing cost management to enhance profitability, while adapting pack sizes and promotional strategies to consumer preferences in different markets. Mondelez anticipates earnings growth into 2026 even with current cocoa prices, driven by productivity improvements, incrementality initiatives in seasonal chocolate, and potential strategic acquisitions, while monitoring the impact of GLP-1 drugs.
Mondelez International (MDLZ) detailed a robust strategy at the 2025 dbAccess Global Consumer Conference, emphasizing its strong geographical diversification—with notable performance in Europe and emerging markets like Brazil—as a key mitigator against regional economic headwinds, such as low US consumer confidence and a cautious Chinese consumer. The company is actively managing significant cocoa price inflation through pricing and revenue growth management (RGM) strategies, which have already impacted approximately 50% of its chocolate revenue, and by adapting pack sizes and promotional activities, particularly in the US where it targets price points under $4 and shifts focus from heavy discounting to in-store brand activations. Financially, Mondelez projects approximately $250 million in SG&A overhead savings for the current year before inflation, reports productivity improvements ahead of schedule, and generated $4 billion in cash flow last year after settling a European Commission fine, underpinning a robust balance sheet. Management expressed confidence in achieving earnings growth into 2026 even if current elevated cocoa prices persist, supported by these cost measures, ongoing distribution expansion adding hundreds of thousands of stores annually, market share gains across key categories, and strategic expansion into adjacent categories such as cakes and pastries, notably through acquisitions like Evert in China. The company also remains open to further bolt-on M&A across four key areas, leveraging its strong cash flow and disciplined capital allocation, while currently seeing no material impact from GLP-1 drugs.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment